SC bars Glenmark from selling copies of Merck diabetes drugs: Sources

The Supreme Court has blocked Glenmark Pharmaceuticals Ltd (GLEN.NS) from selling copies of US drugmaker Merck & Co Inc's (MRK.N) diabetes drugs Januvia and Janumet, sources with knowledge of the matter said after a court hearing on Friday.

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

Merck sued Glenmark in 2013 for infringing a patent it has on sitagliptin, the chemical compound in Januvia and Janumet. Glenmark sells the medicines under the brand names Zita and Zita-met.

(Reuters)